Under the agreement, initial discussions will focus on developing new tests that could make the biggest impact to patient care.
Dave Hickey, senior vice president strategic planning and business development, Siemens Healthcare Diagnostics, said: “This agreement establishes a framework that gives both companies the opportunity to offer new diagnostic tests to laboratories, physicians and their patients more quickly and effectively than either could do alone. Advancing health care for patients is an important commitment that we can reach through strategic relationships such as this.”